The extracellular matrix market is projected to reach US$ 52.72 million by 2028 from US$ 31.49 million in 2021. It is estimated to grow at a CAGR of 7.6% from 2021 to 2028.
The extracellular matrix is present in the outer side of the tissues, and it helps tissues bind the cells with collagen. It consists of structural proteins, glycoproteins, glycosaminoglycans, and proteoglycans. Extracellular matrix enables recipient cells to regrow, and thus, it is used in various applications, including cardiac and vascular repair procedures. Several factors, such as the significant rising incidence of cardiovascular diseases and trauma and an increase in vascular reconstruction procedures, are boosting the extracellular matrix market growth. However, the challenges during the usage of decellularized extracellular matrix hamper the market's growth.
Customize This Report To Suit Your Requirement
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
Extracellular Matrix Market: Strategic Insights
- Get Top Key Market Trends of this report.This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Customize This Report To Suit Your Requirement
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
Extracellular Matrix Market: Strategic Insights
- Get Top Key Market Trends of this report.This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Market Insights
Rising Incidences of Cardiovascular Disorders and Trauma Boosts Extracellular Matrix Market Growth
The significant rise in the cases of orthopedic trauma conditions and cardiovascular diseases is the leading factor behind the growth of the global extracellular matrix market. As a part of the treatment, the extracellular matrix offers several benefits in treating different chronic injuries caused due to surgery, accidents, chronic diseases, and other incidents. Moreover, heart failure and myocardial infarction incidences are increasing among the aging population. The minimally invasive treatment for these cardiovascular treatments procedures requires an extracellular matrix. A patient suffering from heart disease fails to restore the functional properties of cardiac tissue. The extracellular matrix's ability to regrow and promote adaptive repair and regeneration enables patients to recover their normal functions. Also, it has shown promising clinical outcomes for tissue engineering in the treatment of cardiovascular diseases and other health conditions.
Furthermore, the rising incidences of cardiovascular diseases are expected to drive the growth of the extracellular matrix. For instance, according to WHO data published in 2019, an estimated 17.9 million people died from CVDs 2019, representing 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke. According to the European Cardiovascular Disease Statistics report of 2017, in Europe, each year cardiovascular disease (CVD) causes 3.9 million deaths and over 1.8 million deaths in the European Union (EU).
Raw Material-based Insights
Based on the raw material, the extracellular matrix market is segmented into bovine, porcine, and other raw materials. The porcine segment is expected to hold the largest share in the market, whereas, the bovine segment is expected to register the highest CAGR during the forecast period.
Based on the application, the extracellular matrix market has been segmented into soft tissue repair, dural repair , wound healing, cardiac repair, pericardial repair, and vascular repair and reconstruction. The soft tissue repair segment is likely to account for a larger market share in 2021. However, the vascular repair and reconstruction segment is expected to register a higher CAGR in the market during the forecast period.
Various companies operating in the extracellular matrix market are adopting marketing strategies, such as product launches, mergers and acquisitions, collaborations, product innovations, and product portfolio expansions to expand their footprint worldwide, maintain the brand name, and meet the increasing demand from end users.
Extracellular Matrix Market Regional Insights
Extracellular Matrix Market Regional Insights
The regional trends and factors influencing the Extracellular Matrix Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Extracellular Matrix Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
- Get the Regional Specific Data for Extracellular Matrix Market
Extracellular Matrix Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 31.49 Million |
| Market Size by 2028 | US$ 52.72 Million |
| Global CAGR (2021 - 2028) | 7.6% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Raw Material
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
Extracellular Matrix Market Players Density: Understanding Its Impact on Business Dynamics
The Extracellular Matrix Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Extracellular Matrix Market are:
- Anteris
- Aziyo Biologics, Inc
- Coloplast Group
- Cook Biotech, Inc
- DSM Biomedical
Disclaimer: The companies listed above are not ranked in any particular order.
- Get the Extracellular Matrix Market top key players overview
Company Profiles
- Anteris
- Aziyo Biologics, Inc
- Coloplast Group
- Cook Biotech, Inc
- DSM Biomedical
- Baxter
- Medtronic
- Merck KGaA
- MTF Biologics
- Smith & Nephew
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
- Quantitative Structure-Activity Relationship (QSAR) Market
- MEMS Foundry Market
- Electronic Data Interchange Market
- Wheat Protein Market
- Piling Machines Market
- Pharmacovigilance and Drug Safety Software Market
- Virtual Production Market
- Biopharmaceutical Contract Manufacturing Market
- Electronic Shelf Label Market
- Railway Braking System Market
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Raw Material and Application
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Global extracellular matrix market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the U.S. is the largest market for sleep apnea diagnostics. The market growth in the country is attributed to the rising prevalence of wounds and injuries. The growth of the market is mainly driven by the significant rise in cardiovascular disorders among the American population. And, Asia Pacific is the fastest-growing region growing at the CAGR of 8.2% during the forecast period.
The extracellular matrix market majorly consists of the players such as Anteris, Aziyo Biologics, Inc., Coloplast Group, Cook Biotech, Inc., DSM Biomedical, Baxter International, Inc., Medtronic, Merck KGaA, MTF Biologics, and Smith & Nephew, among others
The soft tissue repair segment dominated the global extracellular matrix market and accounted for the largest revenue share of 24.11% in 2021.
The Porcine segment dominated the global extracellular matrix market and held the largest revenue share of 43.76% in 2021.
Extracellular matrix is present in the outer side of the tissues and it helps tissues to bind the cells with collagen. It consists of structural proteins, glycoproteins, glycosaminoglycans and proteoglycans. Extracellular matrix enables recipient cells to regrow and thus it is used in various applications which include cardiac and vascular repair procedure.
Key factors that are driving the growth of this market are rising incidence of cardiovascular diseases and trauma along with increase in vascular reconstruction procedures.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Extracellular Matrix Market
- Anteris
- Aziyo Biologics, Inc
- Coloplast Group
- Cook Biotech, Inc
- DSM Biomedical
- Baxter
- Medtronic
- Merck KGaA
- MTF Biologics
- Smith & Nephew
Get Free Sample For